186 related articles for article (PubMed ID: 16087412)
1. Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study.
Uno T; Yasui-Furukori N; Shimizu M; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):238-43. PubMed ID: 16087412
[TBL] [Abstract][Full Text] [Related]
2. Sensitive determination of omeprazole and its two main metabolites in human plasma by column-switching high-performance liquid chromatography: application to pharmacokinetic study in relation to CYP2C19 genotypes.
Shimizu M; Uno T; Niioka T; Yaui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):241-8. PubMed ID: 16497565
[TBL] [Abstract][Full Text] [Related]
3. Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.
Uno T; Yasui-Furukori N; Takahata T; Sugawara K; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):309-14. PubMed ID: 15664363
[TBL] [Abstract][Full Text] [Related]
4. Direct injection, column switching-liquid chromatographic technique for the estimation of rabeprazole in bioequivalence study.
Singh SS; Jain M; Shah H; Gupta S; Thakker P; Shah R; Lohray BB
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):247-54. PubMed ID: 15556540
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatography method for the quantification of rabeprazole in human plasma using solid-phase extraction.
Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M; Kumar SS
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):209-14. PubMed ID: 15664352
[TBL] [Abstract][Full Text] [Related]
6. A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies.
Akamine Y; Yasui-Furukori N; Kojima M; Inoue Y; Uno T
J Sep Sci; 2010 Nov; 33(21):3292-8. PubMed ID: 21049519
[TBL] [Abstract][Full Text] [Related]
7. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma.
Huang J; Xu Y; Gao S; Rui L; Guo Q
Rapid Commun Mass Spectrom; 2005; 19(16):2321-4. PubMed ID: 16021618
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatography method for the quantification of pantoprazole in human plasma.
Ramakrishna NV; Vishwottam KN; Wishu S; Koteshwara M
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):326-9. PubMed ID: 16005696
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T
Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous estimation of four proton pump inhibitors--lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study.
Bharathi DV; Hotha KK; Jagadeesh B; Chatki PK; Thriveni K; Mullangi R; Naidu A
Biomed Chromatogr; 2009 Jul; 23(7):732-9. PubMed ID: 19360758
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of rabeprazole and its two active metabolites in human urine by liquid chromatography with tandem mass spectrometry and its application in a urinary excretion study.
Simpemba E; Liu R; Sun C; Agbokponto JE; Ding L
J Sep Sci; 2014 Aug; 37(15):1951-6. PubMed ID: 24798930
[TBL] [Abstract][Full Text] [Related]
12. Determination of a new H(+)-K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatography.
Nakai H; Shimamura Y; Kanazawa T; Yasuda S; Kayano M
J Chromatogr B Biomed Appl; 1994 Oct; 660(1):211-20. PubMed ID: 7858718
[TBL] [Abstract][Full Text] [Related]
13. Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status.
Uno T; Shimizu M; Yasui-Furukori N; Sugawara K; Tateishi T
Br J Clin Pharmacol; 2006 Mar; 61(3):309-14. PubMed ID: 16487224
[TBL] [Abstract][Full Text] [Related]
14. Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity.
Yasui-Furukori N; Inoue Y; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):153-7. PubMed ID: 15522714
[TBL] [Abstract][Full Text] [Related]
15. High performance liquid chromatographic method for the determination of cetirizine and ambroxol in human plasma and urine--a boxcar approach.
Dharuman J; Vasudhevan M; Ajithlal T
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2624-31. PubMed ID: 21840269
[TBL] [Abstract][Full Text] [Related]
16. Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.
Yasuda S; Higashi S; Murakami M; Tomono Y; Kawaguchi M
Int J Clin Pharmacol Ther; 1999 May; 37(5):249-53. PubMed ID: 10363624
[TBL] [Abstract][Full Text] [Related]
17. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction.
Miura M; Tada H; Satoh S; Habuchi T; Suzuki T
J Pharm Biomed Anal; 2006 May; 41(2):565-70. PubMed ID: 16442771
[TBL] [Abstract][Full Text] [Related]
18. High performance liquid chromatographic analysis of rabeprazole in human plasma and its pharmacokinetic application.
Park CW; Rhee YS; Go BW; Kam SH; Lee KH; Lee HS; Park ES
Arch Pharm Res; 2008 Sep; 31(9):1195-9. PubMed ID: 18806963
[TBL] [Abstract][Full Text] [Related]
19. Bioequivalence study of rabeprazole sodium on healthy human volunteers.
Mondal U; Ganesan M; Pal TK; Jayakumar M; Chattaraj TK; Roy K; Banerjee SN
J Indian Med Assoc; 2004 Jan; 102(1):26, 28, 30. PubMed ID: 15195855
[TBL] [Abstract][Full Text] [Related]
20. Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes.
Shiohira H; Yasui-Furukori N; Tateishi T; Uno T
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Aug; 879(24):2465-70. PubMed ID: 21783435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
